Table 1 Demographic and clinical characteristics of all participants.
|  | Controls (n = 235) | SCLC (n = 235) | P value |
|---|---|---|---|
Age (years) | 65(59–71) | 65(59–71) | 1 |
Sex (Male/Female) | 55/180 | 55/180 | 1 |
Smoking (%) | 48(20.4%) | 145(61.7%) |  < 0.001 |
Hypertension (%) | 46(19.6%) | 102(43.4%) |  < 0.001 |
BMI (kg/m2) | 24.28 ± 3.15 | 24.86 ± 3.44 | 0.06 |
WBCC (× 10^9/L) | 5.51(4.72–6.83) | 6.63(5.49–8.09) |  < 0.001 |
Neutrophil count (× 10^9/L) | 3.72(2.91–4.80) | 4.54(3.51–5.82) |  < 0.001 |
FBG (mmol/L) | 5.07 ± 0.67 | 5.36 ± 1.17 | 0.001 |
TC (mmol/L) | 4.63 ± 0.78 | 4.61 ± 0.95 | 0.805 |
TG (mmol/L) | 0.82 ± 0.21 | 1.18 ± 0.57 |  < 0.001 |
LDL-C(mmol/L) | 2.88 ± 0.60 | 2.99 ± 0.72 | 0.084 |
HDL-C(mmol/L) | 1.28(1.13–1.54) | 1.14(0.96–1.36) |  < 0.001 |
Uric acid (umol/l) | 293.56 ± 78.32 | 277.40 ± 101.96 | 0.055 |
TyG index | 8.06 ± 0.31 | 8.42 ± 0.48 |  < 0.001 |
TyG-BMI | 195.98 ± 28.27 | 209.81 ± 34.23 |  < 0.001 |
TG/HDL-C | 1.47 ± 0.51 | 2.49 ± 1.55 |  < 0.001 |
METS-IR | 34.44 ± 5.54 | 37.47 ± 6.44 |  < 0.001 |